medical devices

U.S. Senator Orrin Hatch (R-Utah), Ranking Member of the Committee on Finance, today announced an amendment to S. 3187, the Food and Drug Administration Safety and Innovation Act, to repeal the job-killing medical device tax that was included in the $2.6 trillion health spending law enacted last year.

Moog Medical Devices Group (MMDG) is issuing a voluntary recall for certain lots of Curlin Intravenous Administration Sets. Use of the affected sets may cause desanguination (blood loss), an under-delivery of prescribed medication/fluid, or a potential delay in therapy. Continued use of the affected administration sets may cause a potential risk of serious injury or death.

The following REF (catalog) and lot numbers, which were sold and distributed in the U.S. between December 2011 and May 2012, are included in the recall:

TriReme Medical, Inc. (TMI) today announced approval by the U.S. Food and Drug Administration (FDA) of the Glider PTCA Catheter, indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion.
Glider is the world's only torqueable PTCA balloon catheter. Combined with its state of the art tip technology, Glider is designed to perform, even in the most challenging conditions. It is also available in an ultra short balloon length of 4mm designed for focal lesions.

The POWERWAND (from Access Scientific Inc., San Diego), an extended-dwell peripheral IV catheter (PIV), substantially outperforms other catheters in both patient satisfaction and safety, according to a presentation at the recent annual meeting of the Infusion Nurses Society (INS).

The presentation was by Teresa Darst, RN, Director of Vascular Access at Huguley Memorial Medical Center. Huguley (Burleson, Texas) was the first hospital in the nation to fully implement the new technology.